Clopirest-ASP 75 Capsule IR
Marketer
Matias Healthcare Pvt Ltd
Salt Composition
Aspirin (75mg) + Clopidogrel (75mg)
Overview Clopirest-ASP 75 Capsule IR
Clopirest-ASP 75mg Immediate-Release capsules combine two antithrombotic agents to inhibit clot formation within blood vessels. This medication prevents heart attacks and strokes in patients with cardiac conditions and treats acute coronary syndrome. Consistent daily ingestion, ideally with food, at the same time each day, is crucial as per your physician's prescribed regimen. Treatment duration and dosage vary based on the specific condition. Complete the entire course, regardless of symptom improvement. A healthy lifestyle—including a low-fat diet, regular exercise, and smoking cessation—optimizes its efficacy. Common adverse effects encompass dyspepsia, easy bruising, and epistaxis. Increased bleeding risk necessitates caution with sharp objects. Alcohol consumption is generally discouraged. Prior to commencing treatment, disclose any pre-existing hepatic or renal impairments, pregnancy (or pregnancy plans), or breastfeeding to your doctor. Inform your healthcare provider of all concomitant medications, as interactions may occur.
Primary Ingredients of Clopirest-ASP 75 Capsule IR
No text provided. Please provide the text you wish me to rephrase.
Uses of Clopirest-ASP 75 Capsule IR
Preventing heart attacks and strokes; managing acute coronary syndrome.
Common Side effects of Clopirest-ASP 75 Capsule IR:
- Bruise
- Gastrointestinal bleeding
- Increased bleeding tendency
- Nosebleeds
How Clopirest-ASP 75 Capsule IR works:
Clopidogrel and aspirin, combined as Clopirest-ASP 75 IR capsules, offer dual antiplatelet action to help prevent heart attacks. This medication inhibits platelet aggregation, thus reducing the risk of dangerous blood clot development. It's also indicated for the management of acute coronary syndrome.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Clopirest-ASP 75 Capsule IR ingestion poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Clopirest-ASP 75 Capsule IR is contraindicated during pregnancy due to confirmed risk to the fetus. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Clopirest-ASP 75mg immediate-release capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Clopirest-ASP 75 mg immediate-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when taking Clopirest-ASP 75mg immediate-release capsules. Dosage modification may be necessary; physician consultation is advised. Clopirest-ASP 75mg immediate-release capsules are contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Clopirest-ASP 75 mg immediate-release capsules cautiously, potentially requiring dosage modification. Consult a physician for guidance. Clopirest-ASP 75 mg immediate-release capsules are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Clopirest-ASP 75 Capsule IR :
Should you forget a Clopirest-ASP 75 Capsule IR dose, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Clopirest-ASP 75 Capsule IR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |


